Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.99

-2.3%

12:18 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: smh who wrote (3442)	4/17/2001 9:12:57 PM
From: Biomaven	Read Replies (1) of 52153

I think a tracking stock can work if the parent company is scrupulous. Unfortunately GENZ has not behaved well with its offspring, in particular GZTC. I still hold some GZMO because I like their science, but I now view the GENZ connection as a definite negative. On another topic, here's a NY Times article complaining about no FDA nominee for commissioner: April 17, 2001 The Leaderless F.D.A. By WILLIAM B. SCHULTZ WASHINGTON — Although we've heard a good deal about the Bush administration's efficiency in making appointments, it is curious that there appears to be no effort to fill the critical position of commissioner of the Food and Drug Administration. The usual flurry of early rumors about possible candidates has subsided, and there have been no signs since then of any serious moves to settle on a nominee nytimes.com Peter (still recovering from taxes - we get an extra day in Massachusetts and I needed every minute).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next